CurrentEndo
Get Weekly

CurrentEndo coverage · page 16 of 55

Diabetes, Obesity and Metabolism

Briefs 601–640 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Contribution of genetic and environmental factors to obesity indices and their overlap

    Cohort studyObesity

  2. Diabetes Obes Metab

    Comparison of pharmacodynamics and pharmacokinetics of ultra‐rapid‐acting insulin aspart and rapid‐acting insulin aspart around continuous moderate intensity exercise in adults with type 1 diabetes: A randomised controlled trial

    Randomized controlled trialT1D

  3. Diabetes Obes Metab

    Oxidised lipoproteins and the risk of type 2 diabetes mellitus: A 5‐year cohort study on β‐cell dysfunction and prediabetes progression

    Cohort studyT2D & other

  4. Diabetes Obes Metab

    Effects of coaching with data management system intervention or usual care on glycemic control in patients with type 2 diabetes: A multicentre, randomised controlled trial

    Randomized controlled trialT2D & other

  5. Diabetes Obes Metab

    Neuroprotective effects of semaglutide targeting the left temporal lobe in adults with overweight or obesity: A 24‐week multimodal neuroimaging study

    Cohort studyObesity

  6. Diabetes Obes Metab

    Effectiveness of behavioural economics‐based financial incentives and social feedback on glycaemic control and physical activity in adults with newly diagnosed type 2 diabetes: A randomised control trial

    Randomized controlled trialT2D & other

  7. Diabetes Obes Metab

    Safety, feasibility, and dose‐dependent metabolic effects of endoscopic duodenal pulsed electric field therapy in adults with type 2 diabetes: Results from two multicentre proof‐of‐concept studies

    Cohort studyT2D & other

  8. Diabetes Obes Metab

    Early versus late initiation of long‐acting insulin in paediatric and adult diabetic ketoacidosis: A systematic review and meta‐analysis of randomised control trials

    Meta-analysisT1D

  9. Diabetes Obes Metab

    Impact of conventional lipid‐lowering therapy on circulating levels of p roprotein convertase subtilisin/kexin type 9: A systematic review and meta‐analysis of randomised controlled trials

    Meta-analysisLipids & liver

  10. Diabetes Obes Metab

    Transportation noise exposure and incident type 2 diabetes: A retrospective cohort study in a large U.S. healthcare system

    Cohort studyT2D & other

  11. Diabetes Obes Metab

    Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy ( EFFORT ): A 24‐week, randomized, open‐label, multicenter trial

    Randomized controlled trialT2D & other

  12. Diabetes Obes Metab

    Relationship between body mass index and 1 mg dexamethasone suppression test in patients with obesity

    Cohort studyObesity

  13. Diabetes Obes Metab

    Association of four insulin resistance indices with liver‐related adverse outcomes: A prospective cohort study

    Cohort studyLipids & liver

  14. Diabetes Obes Metab

    A treat‐to‐target approach for obesity management: A post hoc analysis of the SURMOUNT ‐5 trial

    Secondary analysisObesity

  15. Diabetes Obes Metab

    Physical activity and meal timing alignment with chronotype and their associations with glucose metabolism: The Maastricht Study

    Cross-sectional studyT2D & other

  16. Diabetes Obes Metab

    Prevalence and predictors of residual gastric content in patients with type 2 diabetes on GLP ‐1 receptor agonists: A prospective observational study

    Cohort studyT2D & other

  17. Diabetes Obes Metab

    Projecting the macroeconomic burden of high body mass index related diseases in China: A Bayesian productivity‐adjusted life years approach based on global burden of diseases 2023

    Cohort studyObesity

  18. Diabetes Obes Metab

    Rationale and design of a parallel randomised trial of a plant‐based intensive lifestyle intervention for diabetes remission: The REmission of diabetes using a PlAnt ‐based weight loss InteRvention ( REPAIR ) trial

    Trial designT2D & other

  19. Diabetes Obes Metab

    Interactive online calculator for estimation of muscle and hepatic insulin sensitivity in adults with Type 1 diabetes using clinical and research biomarkers

    Diagnostic or prognostic studyT1D

  20. Diabetes Obes Metab

    Associations of adipose tissue insulin resistance with fasting blood glucose and HbA1c in adults without diabetes

    Cross-sectional studyT2D & other

  21. Diabetes Obes Metab

    Synergistic effects of hypertension and diabetes on cardiovascular risk in elderly: Comparative longitudinal analysis of CHARLS and HRS

    Cohort studyT2D & other

  22. Diabetes Obes Metab

    Risk stratification using coronary artery calcium and potential benefit of semaglutide therapy: A cost‐effectiveness modelling study

    Research articleObesity

  23. Diabetes Obes Metab

    Early detection of type 2 diabetes mellitus‐associated cognitive dysfunction: The potential of amide proton transfer‐weighted imaging

    Diagnostic or prognostic studyT2D & other

  24. Diabetes Obes Metab

    Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data

    Research articleT2D & other

  25. Diabetes Obes Metab

    Efficacy and safety of GLP ‐1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta‐analysis

    Meta-analysisT1D

  26. Diabetes Obes Metab

    Long‐term weight maintenance and risk of cardiometabolic multimorbidity and its subtypes in middle‐aged and older adults: A pooled landmark analysis in China and the UK

    Meta-analysisT2D & other

  27. Diabetes Obes Metab

    Prevalence of new‐onset diabetes following COVID ‐19 infection: A systematic review and meta‐analysis

    Meta-analysisT2D & other

  28. Diabetes Obes Metab

    Rethinking control‐ IQ + technology: Simple strategies for easy optimization

    Guideline or statementTechnology

  29. Diabetes Obes Metab

    Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trial

    Secondary analysisT1D

  30. Diabetes Obes Metab

    International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring

    Guideline or statementTechnology

  31. Diabetes Obes Metab

    Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal‐bolus insulin therapy: A randomised controlled trial

    Randomized controlled trialT2D & other

  32. Diabetes Obes Metab

    Development of the health economic model for type 2 diabetes considering glycaemic variability

    Secondary analysisT2D & other

  33. Diabetes Obes Metab

    Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double‐blind, placebo‐controlled trial

    Randomized controlled trialT2D & other

  34. Diabetes Obes Metab

    Nutrition interventions for anxiety, depression, stress and/or diabetes‐related distress in individuals with diabetes: A systematic review and meta‐analysis of randomised controlled trials

    Meta-analysisT2D & other

  35. Diabetes Obes Metab

    GLP ‐ 1RAs versus metformin and Parkinson's risk in type 2 diabetes

    Cohort studyT2D & other

  36. Diabetes Obes Metab

    Drug–gene interactions and the risk of diabetic microvascular complications: A population‐based cohort study

    Cohort studyComplications

  37. Diabetes Obes Metab

    An oral glucose tolerance test in pregnancy and its association with future cardiovascular diseases

    Cohort studyDiabetes in pregnancy

  38. Diabetes Obes Metab

    Comparative effectiveness of pharmacotherapy for heart failure with preserved ejection fraction: A systematic review and network meta‐analysis

    Meta-analysisComplications

  39. Diabetes Obes Metab

    Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, Canada

    Cohort studyTechnology

  40. Diabetes Obes Metab

    Evaluating WHtR and WC cut‐offs for abdominal obesity among children and adolescents: Insights from three National Surveys in China

    Cross-sectional studyObesity

All 2,200 Briefs in ExploreShowing Briefs 601–640 of 2,200, newest first